foxo4-dri patent 10mg FOXO4-DRI | Chimera Peptides
FOXO4 DRI Chimera Peptides FOXO4 DRI 99% Purity, COA Included Glow Peptides Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv Buy FOXO4 DRI 15mg Paramount Peptides Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





